Home » Tranzyme Enters Strategic Drug Discovery Collaboration With BMS
Tranzyme Enters Strategic Drug Discovery Collaboration With BMS
Tranzyme Pharma Tuesday announced that it has entered into a strategic
collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds directed against targets of
interest to Bristol-Myers Squibb.
Earth Times
Earth Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May